Published on 9 Aug 2022 on Zacks via Yahoo Finance
Quotient (QTNT) came out with a quarterly loss of $0.37 per share versus the Zacks Consensus Estimate of a loss of $0.28. This compares to loss of $0.24 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of -32.14%. A quarter ago, it was expected that this blood test developer would post a loss of $0.34 per share when it actually produced a loss of $0.25, delivering a surprise of 26.47%.
Over the last four quarters, the company has surpassed consensus EPS estimates just once.